Onyx Scientific Wins Phase I API Contract

Onyx Scientific has been award a contract from Cancer Research UK to develop the chemistry and perform the GMP synthesis of an API for use in a Phase I trial. The technical team at Onyx Scientific was able to improve the synthetic methodology as well as provide an alternative route for the API, which will potentially help make the project more efficient and cost effective in the long term.

Dr. Nigel Westwood, drug supply manager at Cancer Research UK, said, “Having had a very positive experience of using Onyx Scientific’s process development and GMP manufacturing services in the past, they seemed like a strong candidate for this important project.

Denise Bowser, commercial director at Onyx Scientific, said, “We are delighted to be working again with the team at Cancer Research UK on this major project as it clearly indicates confidence in our technical expertise, customer service and ability to deliver on time. The input we have had to date has been positive and has no doubt demonstrated our commitment to go the extra mile for clients by meeting their requirements as efficiently as possible.”